SCHEMBL24309341

SCHEMBL24309341

CSc1cc(-c2ccccc2C(C)C)nc(N)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 1/20 0.45
▸ HTR1B P28222 1/20 0.41
▸ HTR2B P41595 1/20 0.41
▸ GPR65 Q8IYL9 1/20 0.41
▸ HSP90AA1 P07900 5/20 0.39
▸ HSP90AB1 P08238 2/20 0.39
▸ ALOX5AP P20292 1/20 0.38
▸ FEN1 P39748 1/20 0.38
▸ ATR Q13535 1/20 0.38
▸ CYP1A2 P05177 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ MAPK10 P53779 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ CHRNA7 P36544 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29567313 1.00 DHFR (0.45) DHFRHTR1BHTR2BGPR65HSP90AA1
SCHEMBL29566853 0.80 HSP90AA1 (0.53) DHFRHSP90AA1HSP90AB1CYP1A2MEN1
SCHEMBL24309495 0.80 HSP90AA1 (0.53) DHFRHSP90AA1HSP90AB1CYP1A2MEN1
SCHEMBL3946692 0.79 HSP90AA1 (0.64) DHFRHTR1BHTR2BGPR65HSP90AA1
SCHEMBL29566525 0.79 HSP90AA1 (0.64) DHFRHTR1BHTR2BGPR65HSP90AA1
SCHEMBL5749301 0.78 DHFR (0.47) DHFRHTR1BHTR2BGPR65HSP90AA1
SCHEMBL29567149 0.78 HSP90AA1 (0.62) DHFRHTR1BHTR2BGPR65HSP90AA1
Hydrochloric Acid SCHEMBL5748008 0.77 DHFR (0.46) DHFRHTR1BHTR2BGPR65HSP90AA1
SCHEMBL24309264 0.74 ADORA2A (0.66) HSP90AA1HSP90AB1CYP1A2MEN1LMNA
SCHEMBL24309820 0.74 DHFR (0.46) DHFRHTR1BHTR2BGPR65HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230373935-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS, SAN DIEGO 2023-11-23 — — US disclosed
US-20230373935-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS, SAN DIEGO 2023-11-23 — — US disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230373935-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CFTR, SCNN1G, SCNN1B DHFR 1848/4885HTR1B 3417/4885HTR2B 4201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback